Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364501
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-17
First Post:
2024-04-02
Brief Title:
Phase 1 Trial of KH801
Sponsor:
Beijing Kanghong Biopharmaceutical Co Ltd
Organization:
Chengdu Kanghong Pharmaceutical Group Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumors |
Keywords: